Palisade Bio, Inc. (PALI) vs Vanda Pharmaceuticals Inc. (VNDA)
A side-by-side comparison of Palisade Bio, Inc. and Vanda Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PALI
Palisade Bio, Inc.
$1.49HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VNDA
Vanda Pharmaceuticals Inc.
$4.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — PALI vs VNDA
growth of $100 · dividends reinvested · last 10yPALI -100.0% (-71.2%/yr)VNDA -72.8% (-12.2%/yr)VNDA compounded faster over this window
Log scale — wide-divergence pair
PALI VNDA
PALI vs VNDA: by the numbers
- •VNDA is the larger company ($272M vs $259M market cap).
- •Both run net losses; VNDA's is the smaller (-127.41% vs -6388.20% net margin).
Metrics side by side
Valuation
| Metric | PALI | VNDA |
|---|---|---|
| P/S ratio | 517.27 | 1.26 |
| P/B ratio | 2.12 | 1.23 |
Profitability
| Metric | PALI | VNDA |
|---|---|---|
| Gross margin | 0.00% | 92.82% |
| Operating margin | 0.00% | -69.95% |
| Net margin | -6388.20% | -127.41% |
| ROE | -26.24% | -124.83% |
| ROIC | -28.96% | -74.73% |
Growth (annualized)
| Metric | PALI | VNDA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -3.56% |
| Total return CAGR (5Y) | -76.02% | -23.91% |
Frequently asked
- How have PALI and VNDA total returns compared?
- Over the past 10 years, PALI delivered -71.24% and VNDA delivered -11.90% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.